We are currently not allowed to organize a physical meeting with external visitors at Amsterdam UMC. Therefore ImmunoMetNet 2020 will be entirely online. Still, we will make it as interesting and interactive as possible.
FRIDAY NOVEMBER 13th, 2020
9:00 CEST | Session 1
Niels Riksen | Radboudumc, Nijmegen
Immunometabolism in cardiovascular disease
Marianne Boes | UMC Utrecht
Immunometabolic control of invariant NKT cells
Ivan Ramirez Moral | Tom van der Poll lab, Amsterdam UMC
mTOR driven glycolysis governs induction of innate immune responses by bronchial epithelial cells exposed to the bacterial component flagellin
Thiago Patente | Bart Everts lab, LUMC
AMPK signaling is required for intestinal CD103+ dendritic cells to drive tolerogenic responses
More speakers to be confirmed
10:30 – 11:00 – Meet the speaker (virtual) coffee break
11:00 CEST | Session 2
Geert Wiegertjes | Wageningen University & Research
Revealing a striking conservation of macrophage polarization in fish
Paul Coffer | UMC Utrecht
A metabolism-epigenome axis controls early events in CD4+ T cell activation
Begoña Porteiro | Stan van de Graaf lab, Amsterdam UMC
Inhibition of hepatic bile acid uptake lowers obesity-related steatosis, stimulates biliary cholesterol excretion and dampens inflammation and plasma (LDL) cholesterol
Patrick van der Zande | Bruno Guigas lab, Leiden University Medical Center (LUMC)
LKB1 signaling in Dendritic Cells limits hepatic Th17 priming and controls whole-body metabolic homeostasis
12:30 – 14:00 – Meet the speaker (virtual) lunch
14:00 CEST | International Keynote talk
Maxim Artyomov | Washington University School of Medicine in St. Louis (WUSTL, USA)
Itaconate – major metabolic commitment versus minor phenotypes
Activated macrophages accumulate itaconate in very large concentrations. Yet, the degree of immunoregulation observed in Irg1-deficient macrophages is very small (e.g. ~10-20% increase in Il1b secretion). In this presentation, Maxim will describe a major “black-and-white” phenotype in macrophages associated with the deficiency in endogenous itaconate, which reveals its physiological importance.
15:00 CEST | Sponsor Tech sessions
15:00 – Agilent session
David Ferrick | Advances and trends enabling the growth of immune-based cancer research and therapeutics
Seahorse workshop
16:00 – Biolog session
16:15 – Sartorius session
16:30 – Meet the sponsors (virtual) drinks